717
Participants
Start Date
February 28, 2002
Primary Completion Date
June 30, 2003
Study Completion Date
June 30, 2003
Arformoterol tartrate inhalation solution
Arformoterol 50 mcg QD
Arformoterol tartrate inhalation solution
Arformoterol 25 mcg BID
Arformoterol tartrate inhalation solution
Arformoterol 15 mcg BID
Salmeterol MDI
Salmeterol MDI 42 mcg BID
Placebo
Placebo BID MDI
Anniston
Birmingham
Jasper
Mobile
Oxford
Little Rock
Los Angeles
Mirage
Mission Hills
San Diego
Santa Ana
Signal Hill
Colorado Springs
Denver
Wheat Ridge
Clearwater
DeLand
Miami
Ocala
Pensacola
St. Petersburg
Tampa
Atlanta
Austell
Decatur
Bloomington
Evansville
Shawnee Mission
Minneapolis
Charles
Las Vegas
Margate City
South Bound Brook
Albuquerque
Endwell
Ithaca
New York
Charlotte
Raleigh
Spartanburg
Wilmington
Cincinnati
Tulsa
Medford
Pittsburgh
Charleston
Houston
Irving
San Antonio
Chesapeake
Richmond
Tacoma
Sumitomo Pharma America, Inc.
INDUSTRY